Publications by authors named "Philip Comp"

Claim this Profile
P
PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
Eberhard F Mammen, Philip C Comp, Robert Gosselin, Charles Greenberg, W Keith Hoots

Semin Thromb Hemost· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.
James D Douketis, Jeffrey S Ginsberg, Susan Haley, Jim Julian, Miriam Dwyer, Philip C Comp

Thromb Res· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphofructokinase deficiency and portal and mesenteric vein thrombosis.
Mohammad F Madhoun, John T Maple, Philip C Comp

Am J Med Sci· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral thrombin inhibitor dabigatran etexilate vs North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery.

J Arthroplasty· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between arterial elasticity and metabolic syndrome features.
Anette S Fjeldstad, Cecilie Fjeldstad, Luke S Acree, Kevin J Nickel, Polly S Montgomery, Philip C Comp

Angiology· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of obesity on calf blood flow and vascular reactivity in older adults.
Luke S Acree, Philip C Comp, Thomas L Whitsett, Polly S Montgomery, Kevin J Nickel

Dyn Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal melt curve profile during prothrombin 20210G --> A analysis due to the 20209C --> T variant.
S Terence Dunn, Richard A Allen, Francesca Bates, Victoria McNamara, Philip Comp

Blood Coagul Fibrinolysis· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should coagulation tests be used to determine which oral contraceptive users have an increased risk of thrombophlebitis?
Philip C Comp

Contraception· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Clifford W Colwell, Scott D Berkowitz, Jay R Lieberman, Philip C Comp, Jeffrey S Ginsberg

J Bone Joint Surg Am· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early lymphoid progenitors in mouse and man are highly sensitive to glucocorticoids.
Hideya Igarashi, Kay L Medina, Takafumi Yokota, Maria Isabel D Rossi, Nobuo Sakaguchi, Philip C Comp

Int Immunol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment and management of acute venous thromboembolic disease.
Philip C Comp

Thromb Res· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569].
Gary T Kinasewitz, S Betty Yan, Bruce Basson, Philip Comp, James A Russell

Crit Care· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New perspectives on vitamin E: gamma-tocopherol and carboxyelthylhydroxychroman metabolites in biology and medicine.
Kenneth Hensley, Elaine J Benaksas, Roberto Bolli, Philip Comp, Paula Grammas

Free Radic Biol Med· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
Charles W Francis, Scott D Berkowitz, Philip C Comp, Jay R Lieberman, Jeffrey S Ginsberg

N Engl J Med· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery.
Philip C Comp

Pharmacotherapy· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
B lymphopoiesis is active throughout human life, but there are developmental age-related changes.
Maria Isabel D Rossi, Takafumi Yokota, Kay L Medina, Karla P Garrett, Philip C Comp

Blood· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Laboratory issues in diagnosing abnormalities of protein C, thrombomodulin, and endothelial cell protein C receptor.
Kandice Kottke-Marchant, Philip Comp

Arch Pathol Lab Med· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of dalteparin use following total knee arthroplasty: a retrospective analysis.
Philip C Comp, Jeffrey D Miller, Kevin W Mayo, Samuel Wagner, Mason W Russell

Expert Rev Pharmacoecon Outcomes Res· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of cilostazol in patients with intermittent claudication: a randomized, double-blind, placebo-controlled study.
D Eugene Strandness, Ronald L Dalman, Steve Panian, Marc S Rendell, Philip C Comp

Vasc Endovascular Surg· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis